Up-to-Date Procedures in Female Stress Urinary Incontinence Surgery: A Concise Review on Bulking Agents Procedures
Abstract
:1. Introduction
2. Literature Research
3. Characteristics of the Included Studies
4. Bulking Agents Outcomes
5. Bulking Agents for Primary Stress Urinary Incontinence
6. Bulking Agents for Recurrent Stress Urinary Incontinence
7. Bulking Agents vs. Other Surgical Procedures
8. Adverse Events
9. Limitations of the Included Studies
10. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Conflicts of Interest
References
- Zacche, M.M.; Mukhopadhyay, S.; Giarenis, I. Changing surgical trends for female stress urinary incontinence in England. Int. Urogynecol. J. 2018, 30, 203–209. [Google Scholar] [CrossRef] [PubMed]
- Gurol-Urganci, I.; Geary, R.S.; Mamza, J.B.; Duckett, J.; El-Hamamsy, D.; Dolan, L.; Tincello, D.G.; Van Der Meulen, J. Long-term Rate of Mesh Sling Removal Following Midurethral Mesh Sling Insertion Among Women with Stress Urinary Incontinence. JAMA 2018, 320, 1659–1669. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dyer, O. Johnson and Johnson faces lawsuit over vaginal mesh devices. BMJ 2016, 353, i3045. [Google Scholar] [CrossRef] [PubMed]
- Keltie, K.; Elneil, S.; Monga, A.; Patrick, H.; Powell, J.; Campbell, B.; Sims, A.J. Complications following vaginal mesh procedures for stress urinary incontinence: An 8 year study of 92,246 women. Sci. Rep. 2017, 7, 12015. [Google Scholar] [CrossRef]
- Smith, A.; Bevan, D.; Douglas, H.R.; James, D. Management of urinary incontinence in women: Summary of updated NICE guidance. BMJ 2013, 347, f5170. [Google Scholar] [CrossRef] [Green Version]
- Kirchin, V.; Page, T.; Keegan, P.E.; Atiemo, K.O.; Cody, J.D.; McClinton, S. Urethral injection therapy for urinary incontinence in women. Cochrane Database Syst. Rev. 2017, 25, CD003881. [Google Scholar] [CrossRef]
- Abrams, P.; Cardozo, L.; Wagg, A.; Wein, A. (Eds.) Recommendation of the International Scientific Committee: Surgery for urinary incontinence in women. In Proceedings of the 6th International Consultation on Incontinence, Tokyo, Japan, 13–15 September 2016; Health Publications: Paris, France, 2017; pp. 2570–2571. [Google Scholar]
- Leone Roberti Maggiore, U.; Bogani, G.; Meschia, M.; Sorice, P.; Braga, A.; Salavatore, S.; Ghezzi, F.; Serati, M. Urethral bulking agents versus other surgical procedures for the treatment of female stress urinary incontinence: A systematic review and meta-analysi. Eur. J. Obstet. Gynecol. Reprod. Biol. 2015, 189, 48–54. [Google Scholar] [CrossRef]
- Itkonen Freitas, A.M.; Mentula, M.; Rahkola-Soisalo, P.; Tulokas, S.; Mikkola, T.S. Tension-free vaginal tape surgery versus poly-acrylamide hydrogel injection for primary stress urinary incontinence: A randomized clinical trial. J. Urol. 2020, 203, 372–378. [Google Scholar] [CrossRef]
- Sokol, E.R.; Karram, M.M.; Dmochowski, R. Efficacy and Safety of Polyacrylamide Hydrogel for the Treatment of Female Stress Incontinence: A Randomized, Prospective, Multicenter North American Study. J. Urol. 2014, 192, 843–849. [Google Scholar] [CrossRef]
- Mohr, S.; Marthaler, C.; Imboden, S.; Monga, A.; Mueller, M.D.; Kuhn, A. Bulkamid (PAHG) in mixed urinary incontinence: What is the outcome? Int. Urogynecol. J. 2017, 28, 1657–1661. [Google Scholar] [CrossRef]
- Vecchioli-Scaldazza, C.; Morosetti, C.; Azizi, B.; Giannubilo, W.; Ferrara, V. Polyacrylamide hydrogel (bulkamid) in female patients of 80 or more years with urinary incontinence. Int. Braz. J. Urol. 2014, 40, 37–43. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zivanovic, I.; Rautenberg, O.; Lobodasch, K.; Von Bünau, G.; Walser, C.; Viereck, V. Urethral bulking for recurrent stress urinary incontinence after midurethral sling failure. Neurourol. Urodyn. 2017, 36, 722–726. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Altman, D.; Ghilotti, F.; Bellocco, R.; Zetterstrom, J.; Kopp Kallner, H. Transurethral polyacrylamide hydrogel injection therapy in women not eligible for midurethral sling surgery. Female Pelvic Med. Reconstr. Surg. 2017, 23, 318–323. [Google Scholar] [CrossRef] [PubMed]
- Mouritsen, L.; Lose, G.; Møller-Bek, K. Long-term follow-up after urethral injection with polyacrylamide hydrogel for female stress incontinence. Acta Obs. Gynecol Scand. 2014, 93, 209–212. [Google Scholar] [CrossRef]
- Leone Roberti Maggiore, U.; Alessandri, F.; Medica, M.; Gabelli, M.; Venturini, P.L.; Ferrero, S. Outpatient periurethral injections of polyacrylamide hydrogel for the treatment of female stress urinary incontinence: Effectiveness and safety. Arch. Gynecol. Obstet. 2013, 288, 131–137. [Google Scholar] [CrossRef]
- Leone Roberti Maggiore, U.; Alessandri, F.; Medica, M.; Gabelli, M.; Venturini, P.L.; Ferrero, S. Periurethral injection of polyacrylamide hydrogel for the treatment of stress urinary incontinence: The impact on female sexual function. J. Sex Med. 2012, 9, 3255–3263. [Google Scholar] [CrossRef]
- Toozs-Hobson, P.; Al-Singary, W.; Fynes, M.; Tegerstedt, G.; Lose, G. Two-year follow-up of an open-label multicenter study of polyacrylamide hydrogel (Bulkamid(R)) for female stress and stress-predominant mixed incontinence. Int. Urogynecol. J. 2012, 23, 1373–1378. [Google Scholar] [CrossRef] [Green Version]
- Serati, M.; Soligo, M.; Braga, A.; Cantaluppi, S.; Coluccia, A.C.; Di Dedda, M.C.; Salvatore, S.; Cetin, I.; Ghezzi, F. Efficacy and safety of polydimethylsiloxane injection (Macroplastique) for the treatment of female stress urinary incontinence: Results of a series of 85 patients with ≥ 3 years of follow-up. BJU Int. 2019, 123, 353–359. [Google Scholar] [CrossRef] [Green Version]
- Kowalik, C.R.; Casteleijn, F.M.; van Eijndhoven, H.W.F.; Zwolsman, S.E.; Roovers, J.P.W.R. Results of an innovative bulk- ing agent in patients with stress urinary incontinence who are not optimal candidates for mid-urethral sling surgery. Neurourol. Urodyn. 2018, 37, 339–345. [Google Scholar] [CrossRef]
- Futyma, K.; Nowakowski, L.; Gałczyński, K.; Miotla, P.; Rechberger, T. Nonabsorbable urethral bulking agent—Clinical effectiveness and late complications rates in the treatment of recurrent stress urinary incontinence after 2 years of follow-up. Eur. J. Obstet. Gynecol. Reprod. Biol. 2016, 207, 68–72. [Google Scholar] [CrossRef]
- Futyma, K.; Miotła, P.; Gałczyński, K.; Baranowski, W.; Doniec, J.; Wodzisławska, A.; Jóźwik, M.; Oniszczuk, M.; Rechberger, T. An open multicenter study of clinical efficacy and safety of urolastic, an injectable implant for the treatment of stress urinary incontinence: One-year observation. BioMed Res. Int. 2015, 2015, 851823. [Google Scholar] [CrossRef] [PubMed]
- Zada, J.; Farag, F. Urolastic for the treatment of women with stress urinary incontinence: 24-month follow-up. Cent. Eur. J. Urol. 2015, 68, 334–338. [Google Scholar] [CrossRef] [Green Version]
- Zajda, J.; Farag, F. Urolastic—A new bulking agent for the treatment of women with stress urinary incontinence: Outcome of 12 months follow up. Adv. Urol. 2013, 2013, 724082. [Google Scholar] [CrossRef] [PubMed]
- Unger, C.A.; Barber, M.D.; Walters, M.D. Ultrasound Evaluation of the Urethra and Bladder Neck Before and After Transurethral Bulking. Female Pelvic Med. Reconstr. Surg. 2016, 22, 118–122. [Google Scholar] [CrossRef]
- Serati, M.; Giammò, A.; Carone, R.; Ammirati, E.; Gubbiotti, M.; Ruffolo, A.; Salvatore, S.; Scancarello, C.; Castronovo, F.; Caccia, G.; et al. Bulking agents for the treatment of recurrent stress urinary incontinence: A suitable option? Minerva Urol. Nephrol. 2021. Online ahead of print. [Google Scholar] [CrossRef]
- Wasenda, E.J.; Kirby, A.C.; Lukacz, E.S.; Nager, C.W. The female continence mechanism measured by high resolution manometry: Urethral bulking versus midurethral sling. Neurourol. Urodyn. 2018, 37, 1809–1814. [Google Scholar] [CrossRef]
- ICS Standards 2020–2021. 2021. Available online: https://www.ics.org/members/shop/icsstandards20202021 (accessed on 5 April 2021).
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Serati, M.; Braga, A.; Salvatore, S.; Torella, M.; Di Dedda, M.C.; Scancarello, C.; Cimmino, C.; De Rosa, A.; Frigerio, M.; Candiani, M.; et al. Up-to-Date Procedures in Female Stress Urinary Incontinence Surgery: A Concise Review on Bulking Agents Procedures. Medicina 2022, 58, 775. https://doi.org/10.3390/medicina58060775
Serati M, Braga A, Salvatore S, Torella M, Di Dedda MC, Scancarello C, Cimmino C, De Rosa A, Frigerio M, Candiani M, et al. Up-to-Date Procedures in Female Stress Urinary Incontinence Surgery: A Concise Review on Bulking Agents Procedures. Medicina. 2022; 58(6):775. https://doi.org/10.3390/medicina58060775
Chicago/Turabian StyleSerati, Maurizio, Andrea Braga, Stefano Salvatore, Marco Torella, Maria Carmela Di Dedda, Chiara Scancarello, Chiara Cimmino, Andrea De Rosa, Matteo Frigerio, Massimo Candiani, and et al. 2022. "Up-to-Date Procedures in Female Stress Urinary Incontinence Surgery: A Concise Review on Bulking Agents Procedures" Medicina 58, no. 6: 775. https://doi.org/10.3390/medicina58060775